FDA Adverse Event Injury Summary report: N

RESOLUTE INTEGRITY RX

MDR report key: 3081981 · Received April 29, 2013

Report

Report Number
9612164-2013-00486
Event Type
Injury
Date Received
April 29, 2013
Date of Event
April 10, 2013
Report Date
August 12, 2014
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P110013
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS: INHERENT RISK OF PROCEDURE (DISSECTION). CONCLUSIONS: INHERENT RISK OF PROCEDURE (DISSECTION). (B)(4).

Additional Manufacturer Narrative · 1

EVALUATION RESULTS: INHERENT RISK OF PROCEDURE ¿ (MYOCARDIAL INFARCTION). EVALUATION CONCLUSIONS: INHERENT RISK OF PROCEDURE ¿ (MYOCARDIAL INFARCTION). (B)(4).

Description of Event or Problem · 1

DURING INDEX PROCEDURE THE PATIENT HAD A RESOLUTE INTEGRITY DRUG ELUTING STENT IMPLANTED IN THE LAD AND IT WAS REPORTED THAT A DISSECTION OCCURRED. ANOTHER RESOLUTE INTEGRITY DRUG ELUTING STENT WAS IMPLANTED AS TREATMENT IN THE LAD. IT WAS REPORTED THAT THIS EVENT WAS POSSIBLY RELATED TO THE DEVICE AND THE PATIENT RECOVERED WITH TREATMENT .

Description of Event or Problem · 1

CEC HAVE ADJUDICATED THAT THE PATIENT SUFFERED A NON Q WAVE MYOCARDIAL INFARCTION ON THE SAME DATE AS THE INDEX PROCEDURE.

Description of Event or Problem · 1

IT IS REPORTED THAT APPROXIMATELY 9 MONTHS POST THE INDEX PROCEDURE THE PATIENT HAD A SUFFERED AN MI. THE PATIENT UNDERWENT REVASCULARIZATION OF THE RCA (NON TARGET VESSEL) AND ANGIOGRAPHY OF THE LAD ONE DAY POST MI. ONE RESOLUTE INTEGRITY DRUG ELUTING STENT WAS IMPLANTED IN THE RCA DURING THE REVASCULARIZATION. INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT RELATED TO THE STUDY STENT. PATIENT RECOVERED WITH TREATMENT

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
183889 RESOLUTE INTEGRITY RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND 0006126299

Patients

Seq Age Sex Outcome Treatment
1 00053 YR Required Intervention CLOPIDOGREL AND ASPIRIN.